Cargando…
Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study
Currently, data regarding the impact of COVID-19 disease (caused by SARS-CoV-2) on patients with childhood rheumatic diseases are significantly limited. To assess the possible connection, we measured levels of IgA and IgG anti-SARS-CoV-2 antibodies in children with juvenile idiopathic arthritis (JIA...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319559/ https://www.ncbi.nlm.nih.gov/pubmed/35887824 http://dx.doi.org/10.3390/jcm11144060 |
_version_ | 1784755578928627712 |
---|---|
author | Opoka-Winiarska, Violetta Grywalska, Ewelina Korona-Głowniak, Izabela Morawska, Izabela Gosik, Krzysztof Malm, Anna Roliński, Jacek |
author_facet | Opoka-Winiarska, Violetta Grywalska, Ewelina Korona-Głowniak, Izabela Morawska, Izabela Gosik, Krzysztof Malm, Anna Roliński, Jacek |
author_sort | Opoka-Winiarska, Violetta |
collection | PubMed |
description | Currently, data regarding the impact of COVID-19 disease (caused by SARS-CoV-2) on patients with childhood rheumatic diseases are significantly limited. To assess the possible connection, we measured levels of IgA and IgG anti-SARS-CoV-2 antibodies in children with juvenile idiopathic arthritis (JIA) and a control group during the pandemic, prior to the introduction of anti-COVID-19 vaccination. We assessed levels of PD-1 suppressive molecule and inflammatory markers in patients and correlated those results with serological response to SARS-CoV-2. In JIA patients, the activity of the disease was assessed using the Juvenile Arthritis Disease Activity Score 71 (JADAS 71) scale. The study consisted of 96 children, 65 diagnosed with JIA, treated with antirheumatic drugs, and 31 healthy volunteers. In patients with JIA, significantly higher levels of SARS-CoV-2 antibodies in the IgA and IgG were demonstrated compared to the control group. We also found significantly higher serum PD-1 levels in JIA patients and control volunteers who were seropositive for SARS-CoV-2 IgA or IgG antibodies compared to those who were seronegative. The humoral immune response to SARS-CoV-2 infection is associated with the persistent upregulation of PD-1 expression in both JIA patients and healthy children. The clinical significance of the detected disorder requires further careful observation. |
format | Online Article Text |
id | pubmed-9319559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93195592022-07-27 Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study Opoka-Winiarska, Violetta Grywalska, Ewelina Korona-Głowniak, Izabela Morawska, Izabela Gosik, Krzysztof Malm, Anna Roliński, Jacek J Clin Med Article Currently, data regarding the impact of COVID-19 disease (caused by SARS-CoV-2) on patients with childhood rheumatic diseases are significantly limited. To assess the possible connection, we measured levels of IgA and IgG anti-SARS-CoV-2 antibodies in children with juvenile idiopathic arthritis (JIA) and a control group during the pandemic, prior to the introduction of anti-COVID-19 vaccination. We assessed levels of PD-1 suppressive molecule and inflammatory markers in patients and correlated those results with serological response to SARS-CoV-2. In JIA patients, the activity of the disease was assessed using the Juvenile Arthritis Disease Activity Score 71 (JADAS 71) scale. The study consisted of 96 children, 65 diagnosed with JIA, treated with antirheumatic drugs, and 31 healthy volunteers. In patients with JIA, significantly higher levels of SARS-CoV-2 antibodies in the IgA and IgG were demonstrated compared to the control group. We also found significantly higher serum PD-1 levels in JIA patients and control volunteers who were seropositive for SARS-CoV-2 IgA or IgG antibodies compared to those who were seronegative. The humoral immune response to SARS-CoV-2 infection is associated with the persistent upregulation of PD-1 expression in both JIA patients and healthy children. The clinical significance of the detected disorder requires further careful observation. MDPI 2022-07-13 /pmc/articles/PMC9319559/ /pubmed/35887824 http://dx.doi.org/10.3390/jcm11144060 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Opoka-Winiarska, Violetta Grywalska, Ewelina Korona-Głowniak, Izabela Morawska, Izabela Gosik, Krzysztof Malm, Anna Roliński, Jacek Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title | Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title_full | Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title_fullStr | Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title_full_unstemmed | Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title_short | Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study |
title_sort | programmed cell death protein-1 upregulation in response to sars-cov-2 in juvenile idiopathic arthritis: a case-control study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319559/ https://www.ncbi.nlm.nih.gov/pubmed/35887824 http://dx.doi.org/10.3390/jcm11144060 |
work_keys_str_mv | AT opokawiniarskavioletta programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT grywalskaewelina programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT koronagłowniakizabela programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT morawskaizabela programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT gosikkrzysztof programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT malmanna programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy AT rolinskijacek programmedcelldeathprotein1upregulationinresponsetosarscov2injuvenileidiopathicarthritisacasecontrolstudy |